3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
3
Lung Neoplasms
2
Hematopoietic and Lymphatic System Neoplasm
2
Colorectal Neoplasms
2
Smoking Cessation
1
Sedentary Behavior
1
Sarcoma
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Pain
1
Myelodysplastic Syndromes
1
Motor Activity
1
Metastatic Pancreatic Adenocarcinoma
1
Malignant Hepatobiliary Neoplasm
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Hodgkin Disease
1
Hematopoietic and Lymphoid System Neoplasm
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Chronic Pain
1
Chronic Disease
1
Cervical Cancer Screening
1
Carcinoma, Non-Small-Cell Lung
1
Cancer Pain
1
COVID-19
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Alzheimer Disease
1
Agnosia
1
Interventions
Specimen Handling
3
Blood Specimen Collection
3
Surveys and Questionnaires
2
Standard of Care
2
Practice Guidelines as Topic
2
COVID-19 Vaccines
2
COH04S1 COVID-19 vaccine
2
2019-nCoV Vaccine mRNA-1273
2
sotrovimab
1
ciclesonide
1
Therapeutics
1
Telemedicine
1
Sodium Chloride
1
Patient Reported Outcome Measures
1
Observation
1
Nutritional Status
1
Niclosamide
1
IMM-101
1
Exercise Therapy
1
Exercise
1
Educational Status
1
Diagnostic Tests, Routine
1
Data Collection
1
CVnCoV COVID-19 vaccine
1
BNT162 Vaccine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
COVID-19
×
Telemedicine
×
1 year
×
Clear all
NCT04357574
2026-02-06
CORONA-SHIELD
Duke University
Enrolling by invitation
1,000 enrolled